Business
Boston Scientific Says Cyberattack Recovery May Dampen 2027 Growth Outlook
A week-long global IT outage has disrupted Boston Scientific's operations ahead of its annual long-range plan update. The company expects only 2%-4% organic growth in 2027 as it works through recapture rates.
Avalo Therapeutics outlines Phase III plans for IL-1 beta blocker
The Philadelphia-based biotech detailed its lotus trial data and Phase III design for hidradenitis suppurativa at the Cantor Fitzgerald conference.
Spyre Therapeutics bets on combination biologics for autoimmune markets
Spyre CEO highlights combo-therapy strategy and robust cash runway as the company advances SKYLINE and SKYLIGHT trials for IBD and hidradenitis suppurativa.
Empire Company Reports Record Q1 EPS of CAD 1.04, Stock Flat
Canada's largest food distributor posted record quarterly earnings but a slight revenue miss left shares unmoved in premarket trading.
Disc Medicine presents phlebotomy data for PV drug, APOLLO readout still set for Q4
Shares rose after Disc Medicine detailed interim results for DISC-3405 in polycythemia vera and reaffirmed that bitopertin's pivotal APOLLO data is on track for the fourth quarter.
PCA at Jefferies Conference: Tight Supply, Strong Growth
Packaging Corporation of America (PCA) reports robust revenue growth and tight supply at its Jefferies Global Industrials Conference, highlighting its strategic acquisitions and capital investments.
Eaton launches Workbench 360 platform with Autodesk integration
The power management company introduced a software platform connecting electrical equipment data across Autodesk applications, targeting complex building and infrastructure projects.
Smith Micro wins multi-year deal with major U.S. carrier for family safety tech
Smith Micro Software signed a multi-year, multi-SKU agreement expanding its SafePath family safety platform with an unnamed U.S. mobile operator.
AtlasClear Expands Correspondent Clearing Network with Sixth Agreement
AtlasClear Holdings, Inc. announced its sixth correspondent broker-dealer agreement, marking continued growth in its clearing infrastructure.
ZenaTech Drone Unit Wins Irish Aviation Approval for Agricultural Flights
ZenaDrone's SORA authorization from the Irish Aviation Authority permits large-scale autonomous aerial application of fertilizers and other products on Irish farmland.
Mint subsidiary outlines robotics cooperation with Vengine
Hong Kong-based AI and robotics firm Mint’s subsidiary enters a non-binding framework agreement with Vengine to explore product development, manufacturing, and distribution opportunities.
hVIVO Reports H1 Loss as Record Orderbook Signals Turnaround Ahead
Contracted orderbook more than doubles to £72m, but revenue drops 32% to £16.3m and adjusted EBITDA slips to a £4.5m loss. Full-year guidance points to low single-digit loss.
Anthropic Taps Accenture as First Embedded Evaluator for AI Safety Push
Anthropic named Accenture its inaugural embedded evaluator under CEO Dario Amodei's proposal to slow AI development. Both firms will invest at least $1 billion over five years.
CQS New City High Yield Fund to Issue 750,000 Shares From Blocklisting Facility
The closed-end fund will issue 750,000 ordinary shares from its blocklisting facility for cash, with the issuance effective Sept. 21 at 50.6p per share.
Inditex reports profit miss despite strong August sales
Inditex said its earnings fell short of expectations even as August sales remained robust.
Compass Pathways selects Fluence for psilocybin therapy training program
Compass Pathways plc and Fluence will develop a certificate program to train healthcare providers on COMP360, a synthetic psilocybin treatment for treatment-resistant depression, pending FDA approval.
Adagene and Third Arc Bio Expand Partnership with First Lead Selection
Adagene Inc. and Third Arc Bio have expanded their strategic licensing agreement, with Third Arc Bio selecting its first lead candidate under the partnership. The collaboration focuses on cancer immunotherapy using Adagene's NEObody and SAFEbody technology platforms.
Nanox Signs Distribution Deal for Imaging System in Costa Rica
Israeli medical imaging company Nanox partners with Costa Rican distributor SOLME RC to market its Nanox.ARC digital tomosynthesis system in Central America.
Calida Ordered to Pay €6.4M in Lafuma Sale Dispute
Swiss company Calida Group loses first-instance ruling in Paris court, but appeal process remains open. The judgment does not affect the company's 2026 EBIT-margin outlook.
International Paper Focuses on Cost Cuts and Restructuring at Jefferies Conference
International Paper reports on cost improvements, European spin-out, and market segmentation at the Jefferies Global Industrials Conference 2026.
Ex-BoE deputy governor leads trio of ex-central bankers at Fnality
Jon Cunliffe, Jochen Metzger and Ron Berndsen join blockchain settlement firm as it expands into euro and dollar payment systems.
Nasdaq’s $100M Investment Values Payward at $21B as Tokenization Push Accelerates
Nasdaq’s venture arm has invested $100 million in Payward, the parent company of cryptocurrency exchange Kraken, as part of a broader push into tokenized securities, valuing the firm at $21 billion.
Medicus Pharma Posts Phase 2 Results for Gorlin Syndrome Skin Cancer Drug
The company posted results from its SKNJCT-003 trial of SkinJect for nodular basal cell carcinoma, selected a 200-microgram dose for further development and said an FDA-authorized Phase 2b study is underway.
QumulusAI completes GPU deployment at Philadelphia colocation site
The distributed AI cloud platform activated its full NVIDIA Blackwell B300 capacity under an $18 million, two-year take-or-pay agreement announced in July.
TTM Technologies to Issue $500M Senior Notes Due 2034
The Santa Ana‑based firm will privately place $500 million of senior unsecured notes, guaranteed by subsidiaries, to fund its proposed acquisition of Epiq Solutions and other corporate purposes.